ISO 13485:2016 and Medical Additive Manufacturing: Sourcing Printed Devices and Implants

ISO 13485:2016 shares structure with ISO 9001 but is built for regulated medical manufacturing, and several of its clauses are decisive for additive. Clause 7.3 (design and development) imposes design controls with documented inputs, outputs, verification, validation, and a design history file, which for patient-matched additive devices is where the per-patient design workflow must be controlled, including the software that converts imaging data into a build file. Clause 7.5.6 (validation of processes for production) mandates validation of any process whose output cannot be verified by later inspection, and a powder bed build is the textbook case: porosity and incomplete fusion are not visible on a finished implant. Clause 7.5.7 adds a specific requirement to validate sterilization and sterile barrier processes, which matters because additive lattice structures and internal channels are hard to clean and sterilize, and residual powder trapped in a porous structure is a real contamination risk. The shop must validate cleaning and depowdering as a controlled process, not an afterthought. Clause 7.5.9 (traceability) is stricter than ISO 9001, requiring records that allow a device to be traced back through its components and processing, and for implantable devices the traceability requirements are heightened so a specific implant can be tied to its powder lot, build, and post-processing. Risk management runs through the whole standard via the link to ISO 14971, so the additive process risks, including powder reuse effects on material properties, build orientation effects on strength, and trapped powder, must be analyzed and controlled within the device risk file rather than treated as shop-floor lore.

ISO 13485 is rarely the only thing in play. In the United States, an additive medical manufacturer typically operates under FDA 21 CFR Part 820, the Quality System Regulation, and ISO 13485 is closely harmonized with it, especially as FDA transitions toward the Quality Management System Regulation that aligns with 13485. The FDA has issued additive-specific guidance (the technical considerations for additive manufactured medical devices) covering design, process validation, material controls, and testing, and a serious additive medical shop will reference it. For the European market, ISO 13485 underpins conformity under the EU MDR, and the notified body will expect the additive process to be validated and the device technical documentation to reflect it. For implants, biocompatibility under ISO 10993 governs the materials and any residuals from printing and post-processing, which is why trapped powder and cleaning validation are not paperwork exercises. The common medical additive materials, titanium Ti-6Al-4V ELI (extra low interstitial, Grade 23) for orthopedic and dental implants, cobalt-chrome for certain implants and dental frameworks, and biocompatible polymers like PEEK and certain photopolymers for surgical guides, are chosen as much for their biocompatibility data as their mechanical behavior. The certificate confirms a system; the regulatory pathway confirms the device is allowed to exist.

ISO 13485 certificates are issued by accredited certification bodies, so confirm the body is accredited (ANAB, BSI, TUV, DEKRA and similar) and verify the certificate in the body's registry or via the IAF database, checking that the scope names medical device manufacturing and, ideally, additive or the relevant process and product class. A scope limited to 'distribution' or 'machining of components' does not cover printing finished devices. Confirm currency against the three-year cycle with annual surveillance, and for EU market access check whether the supplier also holds the notified-body certification relevant to your device class. The records that should arrive with a medical additive job go beyond a generic CofC. Expect the device master record references, material certification tracing the powder or resin lot to its biocompatibility and chemistry, the build and post-processing records, cleaning and depowdering validation evidence applicable to the lot, sterilization validation or the sterilization indicator records if the shop sterilizes, and dimensional and any mechanical or density inspection you specified. For implantable devices, the heightened traceability means you should be able to tie a serial-controlled device to its full processing history. If the supplier cannot produce design control and validation evidence, the certificate is not being applied to your product the way the standard requires.